From the publisher feed

Radical Numerics turned heads with its announcement about a novel treatment. Now a former partner, Tabula Bioscience, says it performed much of the research.

Read the original at The New York Times ↗

Opens the original publisher page. Access, copyright and subscriptions are controlled by the publisher.

A useful next step

  1. Read the short publisher description here.
  2. Open the full report directly at the publisher.
  3. Compare this topic with other sources when useful.